Topic: United States
NEW YORK (Reuters) - Bristol-Myers Squibb Co and Johnson & Johnson plan to jointly develop experimental treatments for hepatitis C in a market worth billions of dollars.The drugs being developed by the two companies work by blocking different proteins than those attacked ...
MADISON, Wis (Reuters) - A Wisconsin health clinic said on Monday it was notifying 2,345 patients that a former employee may have exposed some of them to blood-borne diseases such as Hepatitis or HIV from 2006 through 2011.The Madison, Wisconsin-based Dean Clinic ...
Some 10 million people who inject illegal drugs have hepatitis C while 1.2 million have hepatitis B, according to the first global estimate of infection rates among this population, published Thursday.Both viral diseases are debilitating and potentially deadly, and public health officials ...
NEW YORK (Reuters Health) - Programs that give injection drug users clean needles or safer drug substitutes may help cut their odds of contracting the liver infection hepatitis C, a new study suggests.The hepatitis C virus is passed through contact with infected ...
The US Food and Drug Administration on Monday approved Incivek to treat hepatitis C when taken along with the current two-drug regimen, marking the second such drug approval this month."The sustained virologic response for patients treated with Incivek across all studies, and ...
NEW YORK (Reuters) - Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, heralding a new era of treatment for the liver-destroying condition.The approval, announced by the Food and Drug Administration said on Monday, was widely expected after an FDA ...
CHICAGO (Reuters) - Hepatitis C infections are rising quickly among white youth in Massachusetts, fueled by increases in the use of heroin and other injection drugs, local and federal health researchers said Thursday.Cases of the infection -- a leading cause of liver ...
NEW YORK (Reuters Health) - African Americans with liver cancer are less likely than whites to get a transplant for the disease, according to U.S. researchers.And that gap hasn't changed in a decade, they report in the journal Cancer."This treatment is expensive, ...
SILVER SPRING, Maryland (Reuters) - A Merck & Co drug that boosts the chance of curing hepatitis C infection moved closer to the U.S. market on Wednesday as an advisory panel unanimously recommended approval.The Merck drug and a rival from Vertex Pharmaceuticals ...
A cocktail of three drugs, including a new class of antiviral agent, has shown encouraging results in treating hepatitis C, a disease which attacks the liver, a study said Wednesday."This study represents a remarkable advance and a potential cure for people with ...